期刊文献+

EB病毒感染对骨髓瘤细胞生物学特性的影响 被引量:2

Effects of Epstein-Barr virus on the phenotypic and biological characteristics of multiple myeloma cells
下载PDF
导出
摘要 运用B95-8细胞株培养上清中的EB病毒体外感染人多发性骨髓瘤(MM)细胞株RPMI8226,通过流式细胞仪(FCM)和Westernblot检测感染后病毒抗原LMP1和EBNA-2的表达。然后再采用FCM和RT-PCR方法,检测感染后细胞表面CD40L和CXCR4的表达。并且进一步通过细胞凋亡检测和Transwell,观察感染后细胞生物学功能的改变。结果显示,RPMI8226细胞感染后表达LMP1和EBNA-2;感染后细胞上调表达CD40L,细胞凋亡减少。而且,通过趋化性细胞因子受体CXCR4表达增高,感染细胞的迁移能力也得到增强。 In this study, the human multiple myeloma cell line RPMI8226 was infected using Epstein-Barr virus (EBV) in the supernatants of the infected B95-8 cell cultures. The expression of LMP1 and EBNA-2 antigens after infection was determined by flow cytometery(FCM) and Western blotting, and that of CD40L and CXCR4 were to be assayed by FCM and RT-PCR. In addition, the changes of the biological characteristics of the infected cells were detected through the detection of cell apoptosis and by transwell. Experimental results showed that the infected RPMI8226 cells expressed LMP1 and EBNA-2 antigens after infection with EBV, and this infected cells could up-regulated the expression of CD40L, which might be involved in the anti-apoptotic function. Also, the mi- grating ability of the infected cells was enhanced by the up-regulation of the chemokine receptor CXCR4.
出处 《现代免疫学》 CAS CSCD 北大核心 2005年第6期476-480,共5页 Current Immunology
基金 国家自然科学基金重点资助项目(30330540) 江苏省135重点实验室基金资助项目
关键词 EPSTEIN-BARR病毒 多发性骨髓瘤 CD40配体 CXCR4 . Epstein-Barr virus multiple myeloma CD40 ligand CXCR4
  • 相关文献

参考文献14

  • 1Gottsehalk S, Heslop HE, Rooney CM. Adoptive immunotherapy for EBV-associated malignancies [J]. Leuk Lymphoma, 2005,46(1):1-10.
  • 2Zimber-Strobl U, Kempkes B, Marschall G, et al. Epstein-Barr virus latent membrane protein (LMP1) is not strfficient to maintain proliferation of B cells but both it and activated CD40 can prolong their survival[J]. EMBO J, 1996,15(24):7070-7078.
  • 3Challa A, Eulopulos AG, Holder M J, et al. Population depletion activates autonomous CD154-dependent survival in biopsy-like Burkitt's lymphoma cells[J]. Blood, 2002,99(9):3411-3418.
  • 4James RB,Robert AV.HHV-8 is present in multiple myeloma patients[J].Blood,1999,93(8):3157-3159.
  • 5Zhou ZH, Wang JF, Wang YD. An agonist anti-human CD40 monoclonal antibody that induce dendritic cell formation and maturation and inhibits proliferation of a myeloma cell line [J].Hybirdoma, 1999,18(6):471-476.
  • 6樊一笋,张学光,邱玉华,朱华亭,於葛华.两株抗人CD40配体单克隆抗体的制备及生物学特性的研究[J].中国免疫学杂志,2002,18(6):388-391. 被引量:8
  • 7Oh HM, Oh JM, Choi SC, et al. An efficient method for the rapid establishment of Epstein-BraT virus immortalization of human B lymphocytes[J]. Cell Prolif, 2003,36(4):191-198.
  • 8Busch LK, Bishop CA. The EBV transforming protein, LMP1,mimics and cooperates with CD40 signaling in B lymphocyte[J]. J Immunol, 1999,162(5): 2555-2561.
  • 9Uchida J, Yasui T, Kikutani H, et al. Mimicry of C40 signals by EBV LMP1 in B lymphocyte responses [J]. Science, 1999,286(5438):300-303.
  • 10周桓,顾宗江,张学光.CD40分子在树突状细胞中的信号转导通路[J].现代免疫学,2004,24(5):429-431. 被引量:2

二级参考文献29

  • 1[1]Armitage R J, Faoslow W C, Strokbine L et al. Molecular and biological characterization of a murine ligand for CD40[J]. Nature, 1992;357:80
  • 2[2]Villa A, Notarangelo L D, Di santo et al. Organization of the human CD40L gene: implications for molecular defects in chromosome-linked hyper-lgM syndrome and prenatal diagnosis[J]. Proc Natl Acad Sci USA, 1994;91:2110
  • 3[3]Durie F H, Foy T M foy, Aruffo A et al. The role of CD40 in the regulation of humoral and cell mediated immunity[J]. Immunol Today, 1994;15:406
  • 4[4]Datta S K, Kalled et al. CD40-CD40L interaction in autoimmtme disease [J]. Arthritis Rhcum, 1997 ;40:1735
  • 5[5]Larson C P,Elwood E T et al. Long-term acceptanc of skin and cardiac allgrafts after blocking CD40 and CL28 pathways[ J]. Nature, 1996;381:434
  • 6[6]Zhauhua Zhou, Jiangfang Wang, Xueguang Zhang et al. An angonist antihuman CD40 monoclonal antibody that induces dendritic cell formation and muraturation and inhibits proliferation of a myeloma cell line[ J]. Hybridoma, 1999; 18:471
  • 7[7]Zor T, Selinger. Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies[J]. Anal Biochem, 1996;15:236
  • 8[8]Sun H, Subbotin V, Chon C et al. Prevontion of chronic rejection in mouse aortic allografts by combined tretment with CTLA4-1g and antiCD40 ligand monoclonal antibody[J] .Transplantation, 1997;64:1838
  • 9[9]Zheng X X,Schachter A D, Vasconcellosl et al. Incronsed CD40 ligand gene expression during human renal and murine islet allograft rejection [J]. Transplantation, 1998 ;65:1512
  • 10[10]Kirk A D,Burkly L C, Batty D S et al . Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman parimates[J] .Nature Med,1999;5:686

共引文献8

同被引文献7

引证文献2

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部